Date Filed | Type | Description |
09/10/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
09/09/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/06/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
09/06/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
09/06/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
09/03/2013 |
4
| HAVRON ABRAHAM (CEO) has filed a Form 4 on PROLOR Biotech, Inc. |
09/03/2013 |
4
| STERN ADAM K (Director) has filed a Form 4 on PROLOR Biotech, Inc.
Txns:
| Disposed/sold 275,000 shares
@ $0 Disposed/sold 10,000 options to buy
@ $4.52, valued at
$45.2k
Disposed/sold 40,000 options to buy
@ $4.74, valued at
$189.6k
|
|
09/03/2013 |
4
| FARES FUAD (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
09/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/03/2013 |
4
| GORECKI MARIAN (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
09/03/2013 |
4
| Rubin Steven D (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
09/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/03/2013 |
4
| NOVIK SHAI A (President) has filed a Form 4 on PROLOR Biotech, Inc. |
08/30/2013 |
8-K
| Quarterly results |
08/30/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
08/09/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
07/24/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
07/15/2013 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
06/12/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
06/07/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/06/2013 |
4
| HAVRON ABRAHAM (CEO) has filed a Form 4 on PROLOR Biotech, Inc. |
06/06/2013 |
4
| FROST PHILLIP MD ET AL (10% Owner) has filed a Form 4 on PROLOR Biotech, Inc.
Txns:
| Granted 542,000 options to buy
@ $0 |
|
06/06/2013 |
4
| FARES FUAD (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
06/06/2013 |
4
| NOVIK SHAI A (President) has filed a Form 4 on PROLOR Biotech, Inc. |
06/06/2013 |
4
| HSIAO JANE PH D (Director) has filed a Form 4 on PROLOR Biotech, Inc.
Txns:
| Granted 40,000 options to buy
@ $0 |
|
06/06/2013 |
4
| GORECKI MARIAN (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
06/06/2013 |
4
| Rubin Steven D (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
06/06/2013 |
4
| STERN ADAM K (Director) has filed a Form 4 on PROLOR Biotech, Inc. |
06/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/04/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
06/04/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
05/30/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/10/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
|